Literature DB >> 24616401

Refining the structure and content of clinical genomic reports.

Michael O Dorschner, Laura M Amendola, Brian H Shirts, Lesli Kiedrowski, Joseph Salama, Adam S Gordon, Stephanie M Fullerton, Peter Tarczy-Hornoch, Peter H Byers, Gail P Jarvik.   

Abstract

To effectively articulate the results of exome and genome sequencing we refined the structure and content of molecular test reports. To communicate results of a randomized control trial aimed at the evaluation of exome sequencing for clinical medicine, we developed a structured narrative report. With feedback from genetics and non-genetics professionals, we developed separate indication-specific and incidental findings reports. Standard test report elements were supplemented with research study-specific language, which highlighted the limitations of exome sequencing and provided detailed, structured results, and interpretations. The report format we developed to communicate research results can easily be transformed for clinical use by removal of research-specific statements and disclaimers. The development of clinical reports for exome sequencing has shown that accurate and open communication between the clinician and laboratory is ideally an ongoing process to address the increasing complexity of molecular genetic testing.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Clinical Laboratory Improvement Amendments (CLIA); College of American Pathologists (CAP); exome sequencing; incidental findings; laboratory report

Mesh:

Year:  2014        PMID: 24616401      PMCID: PMC4077592          DOI: 10.1002/ajmg.c.31395

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  11 in total

1.  Clinical laboratory reports in molecular pathology.

Authors:  Margaret L Gulley; Rita M Braziel; Kevin C Halling; Eric D Hsi; Jeffrey A Kant; Marina N Nikiforova; Jan A Nowak; Shuji Ogino; Andre Oliveira; Herbert F Polesky; Lawrence Silverman; Raymond R Tubbs; Vivianna M Van Deerlin; Gail H Vance; James Versalovic
Journal:  Arch Pathol Lab Med       Date:  2007-06       Impact factor: 5.534

2.  Clinician perspectives about molecular genetic testing for heritable conditions and development of a clinician-friendly laboratory report.

Authors:  Ira M Lubin; Margaret M McGovern; Zoe Gibson; Susan J Gross; Elaine Lyon; Roberta A Pagon; Victoria M Pratt; Jamila Rashid; Colleen Shaw; Lander Stoddard; Tracy L Trotter; Marc S Williams; Jean Amos Wilson; Kenneth Pass
Journal:  J Mol Diagn       Date:  2009-02-05       Impact factor: 5.568

3.  A report template for molecular genetic tests designed to improve communication between the clinician and laboratory.

Authors:  Maren T Scheuner; Lee Hilborne; Julie Brown; Ira M Lubin
Journal:  Genet Test Mol Biomarkers       Date:  2012-06-25

4.  Actionable, pathogenic incidental findings in 1,000 participants' exomes.

Authors:  Michael O Dorschner; Laura M Amendola; Emily H Turner; Peggy D Robertson; Brian H Shirts; Carlos J Gallego; Robin L Bennett; Kelly L Jones; Mari J Tokita; James T Bennett; Jerry H Kim; Elisabeth A Rosenthal; Daniel S Kim; Holly K Tabor; Michael J Bamshad; Arno G Motulsky; C Ronald Scott; Colin C Pritchard; Tom Walsh; Wylie Burke; Wendy H Raskind; Peter Byers; Fuki M Hisama; Deborah A Nickerson; Gail P Jarvik
Journal:  Am J Hum Genet       Date:  2013-09-19       Impact factor: 11.025

5.  Medicare and Medicaid programs: hospital outpatient prospective payment and ambulatory surgical center payment systems and quality reporting programs; Hospital Value-Based Purchasing Program; organ procurement organizations; quality improvement organizations; Electronic Health Records (EHR) Incentive Program; provider reimbursement determinations and appeals. Final rule with comment period and final rules.

Authors: 
Journal:  Fed Regist       Date:  2013-12-10

6.  Good laboratory practices for molecular genetic testing for heritable diseases and conditions.

Authors:  Bin Chen; MariBeth Gagnon; Shahram Shahangian; Nancy L Anderson; Devery A Howerton; Joe D Boone
Journal:  MMWR Recomm Rep       Date:  2009-06-12

7.  ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007.

Authors:  C Sue Richards; Sherri Bale; Daniel B Bellissimo; Soma Das; Wayne W Grody; Madhuri R Hegde; Elaine Lyon; Brian E Ward
Journal:  Genet Med       Date:  2008-04       Impact factor: 8.822

8.  A survey of informatics approaches to whole-exome and whole-genome clinical reporting in the electronic health record.

Authors:  Peter Tarczy-Hornoch; Laura Amendola; Samuel J Aronson; Levi Garraway; Stacy Gray; Robert W Grundmeier; Lucia A Hindorff; Gail Jarvik; Dean Karavite; Matthew Lebo; Sharon E Plon; Eliezer Van Allen; Karen E Weck; Peter S White; Yaping Yang
Journal:  Genet Med       Date:  2013-09-26       Impact factor: 8.822

9.  ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.

Authors:  Robert C Green; Jonathan S Berg; Wayne W Grody; Sarah S Kalia; Bruce R Korf; Christa L Martin; Amy L McGuire; Robert L Nussbaum; Julianne M O'Daniel; Kelly E Ormond; Heidi L Rehm; Michael S Watson; Marc S Williams; Leslie G Biesecker
Journal:  Genet Med       Date:  2013-06-20       Impact factor: 8.822

Review 10.  Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium.

Authors:  Jonathan S Berg; Laura M Amendola; Christine Eng; Eliezer Van Allen; Stacy W Gray; Nikhil Wagle; Heidi L Rehm; Elizabeth T DeChene; Matthew C Dulik; Fuki M Hisama; Wylie Burke; Nancy B Spinner; Levi Garraway; Robert C Green; Sharon Plon; James P Evans; Gail P Jarvik
Journal:  Genet Med       Date:  2013-10-24       Impact factor: 8.822

View more
  13 in total

Review 1.  First Responder to Genomic Information: A Guide for Primary Care Providers.

Authors:  Susanne B Haga
Journal:  Mol Diagn Ther       Date:  2019-08       Impact factor: 4.074

2.  Educating patients and providers through comprehensive pharmacogenetic test reports.

Authors:  Susanne B Haga
Journal:  Pharmacogenomics       Date:  2017-07-07       Impact factor: 2.533

Review 3.  The ins and outs of molecular pathology reporting.

Authors:  Véronique Tack; Kelly Dufraing; Zandra C Deans; Han J van Krieken; Elisabeth M C Dequeker
Journal:  Virchows Arch       Date:  2017-03-26       Impact factor: 4.064

4.  Physician Experiences and Understanding of Genomic Sequencing in Oncology.

Authors:  Caroline M Weipert; Kerry A Ryan; Jessica N Everett; Beverly M Yashar; Arul M Chinnaiyan; J Scott Roberts; Raymond De Vries; Brian J Zikmund-Fisher; Victoria M Raymond
Journal:  J Genet Couns       Date:  2017-08-24       Impact factor: 2.537

5.  Barriers to clinical adoption of next-generation sequencing: a policy Delphi panel's solutions.

Authors:  Donna A Messner; Pei Koay; Jennifer Al Naber; Robert Cook-Deegan; Mary Majumder; Gail Javitt; Rachel Dvoskin; Juli Bollinger; Margaret Curnutte; Amy L McGuire
Journal:  Per Med       Date:  2017-06-23       Impact factor: 2.512

6.  The challenge of comprehensive and consistent sequence variant interpretation between clinical laboratories.

Authors:  Melanie G Pepin; Mitzi L Murray; Samuel Bailey; Dru Leistritz-Kessler; Ulrike Schwarze; Peter H Byers
Journal:  Genet Med       Date:  2015-04-02       Impact factor: 8.822

7.  Development of clinical decision support alerts for pharmacogenomic incidental findings from exome sequencing.

Authors:  Adam A Nishimura; Brian H Shirts; Michael O Dorschner; Laura M Amendola; Joe W Smith; Gail P Jarvik; Peter Tarczy-Hornoch
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

8.  Developing patient-friendly genetic and genomic test reports: formats to promote patient engagement and understanding.

Authors:  Susanne B Haga; Rachel Mills; Kathryn I Pollak; Catherine Rehder; Adam H Buchanan; Isaac M Lipkus; Jennifer H Crow; Michael Datto
Journal:  Genome Med       Date:  2014-07-31       Impact factor: 11.117

9.  An informatics research agenda to support precision medicine: seven key areas.

Authors:  Jessica D Tenenbaum; Paul Avillach; Marge Benham-Hutchins; Matthew K Breitenstein; Erin L Crowgey; Mark A Hoffman; Xia Jiang; Subha Madhavan; John E Mattison; Radhakrishnan Nagarajan; Bisakha Ray; Dmitriy Shin; Shyam Visweswaran; Zhongming Zhao; Robert R Freimuth
Journal:  J Am Med Inform Assoc       Date:  2016-04-23       Impact factor: 4.497

10.  Prospective participant selection and ranking to maximize actionable pharmacogenetic variants and discovery in the eMERGE Network.

Authors:  David R Crosslin; Peggy D Robertson; David S Carrell; Adam S Gordon; David S Hanna; Amber Burt; Stephanie M Fullerton; Aaron Scrol; James Ralston; Kathleen Leppig; Andrea Hartzler; Eric Baldwin; Mariza de Andrade; Iftikhar J Kullo; Gerard Tromp; Kimberly F Doheny; Marylyn D Ritchie; Paul K Crane; Deborah A Nickerson; Eric B Larson; Gail P Jarvik
Journal:  Genome Med       Date:  2015-07-03       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.